（文章来源：证券日报） 证券日报网讯 1月30日，海波重科发布公告称，公司预计2025年度归属于上市公司股东的净利润为900 万元～1，330万元。 ...

南财智讯1月30日电，海波重科发布2025年度业绩预告，预计2025年全年归属于上市公司股东的净利润 为900万元—1330万元，同比预减42.18%—60.88%；预计2025年全年归属于上市公司股东的扣除非经常 性损益的净利润为285万元—420万元，同比预减56.05%—70.18%。报告期内公司业绩出现下滑，主要 系桥梁钢结构工程主业面临显著经营压力。受已完工项目工程款支付进度滞后、行业市场竞争加剧倒逼 项目定价下行等因素影响，公司为保障经营稳健性，在项目利润与付款条件之间进行审慎权衡后开展市 场经营活动，进而导致工程承接合同金额同比缩减，2025年度营业收入因此出现同比下滑，叠加公司产 能较大，在产量不饱和的状态下，固定成本分摊压力凸显，对利润空间形成进一步挤压。上述多重因素 叠加共振，最终造成公司报告期内净利润下降。 ...

海波重科公告，预计2025年度净利润为900万元至1330万元，同比下降42.18%～60.88%。报告期内公司 业绩出现下滑，主要系桥梁钢结构工程主业面临显著经营压力。受已完工项目工程款支付进度滞后、行 业市场竞争加剧倒逼项目定价下行等因素影响，公司为保障经营稳健性，在项目利润与付款条件之间进 行审慎权衡后开展市场经营活动，进而导致工程承接合同金额同比缩减，2025年度营业收入因此出现同 比下滑，叠加公司产能较大，在产量不饱和的状态下，固定成本分摊压力凸显，对利润空间形成进一步 挤压。 ...

证券代码：300517 证券简称：海波重科 公告编号：2026-004 海波重型工程科技股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为正值且属于同向下降 50%以上情形 （1）以区间数进行业绩预告的 单位：万元 二、与会计师事务所沟通情况 本期业绩预告相关的财务数据未经会计师事务所预审计。公司已就业绩预告有关事项 与会计师事务所进行了预沟通，公司与会计师事务所在业绩预告方面不存在重大分歧。 三、业绩变动原因说明 报告期内公司业绩出现下滑，主要系桥梁钢结构工程主业面临显著经营压力。受已完 工项目工程款支付进度滞后、行业市场竞争加剧倒逼项目定价下行等因素影响，公司为保 障经营稳健性，在项目利润与付款条件之间进行审慎权衡后开展市场经营活动，进而导致 工程承接合同金额同比缩减，2025 年度营业收入因此出现同比下滑，叠加公司产能较大， 在产量不饱和的状态下，固定成本分摊压力凸显，对利润空间形成 ...

中国经济网北京1月13日讯 海波重科(300517.SZ)12日披露关于公司控股股东、实际控制人减持计划预披 露公告，公司于近日收到控股股东、实际控制人张海波出具的告知函，张海波以大宗交易方式减持股份 不超过3,990,000股（即不超过公司总股本的1.99%，不超过公司扣除回购专用账户股份后总股本的 2.00%），且受让方6个月内不得转让其受让的股份；以集中竞价方式减持股份不超过1,990,000股（即 不超过公司总股本的0.99%，不超过公司扣除回购专用账户股份后总股本的1.00%）。 (责任编辑：孙辰炜) | 序号 | 股东名称 | 持股数量(股) | 占公司总股本 | 占公司扣除回购专用账 | | --- | --- | --- | --- | --- | | | | | 的比例 | 户股份后总股本的比例 | | 1 | 张海波 | 98.868.500 | 49. 33% 49. 47% | | 张海波最初持股1.02亿股，占总股本的50.81%。张海波从2025年8月5日起，第一次减持海波重科股份， 迄今为止，累计减持公司股票295.75万股，累计套现约3566.5万元。叠加本次减持，将累计减持1 ...

Group 1 - Weiteou signed a strategic cooperation agreement with Qiteng Robotics to focus on safety upgrades in high-risk industries, leveraging new materials and robotics [1] - Dongfang Caifu's subsidiary received approval from the CSRC to issue subordinate bonds totaling up to 20 billion yuan [2] - Haibo Zhongke's controlling shareholder plans to reduce holdings by up to 2.98% of the company's shares [3] Group 2 - Shengyang Technology's subsidiary FTA is expanding into the foreign satellite internet terminal business, which is still in the early commercialization stage [4] - Cangge Mining expects a net profit increase of 43.41%-53.1% for 2025, projecting a profit of 3.7-3.95 billion yuan [5] - Jinlongyu plans to invest approximately 1.2 billion yuan to build a production line for solid-state batteries with an annual capacity of 2 GWh [6] Group 3 - Shengda Resources intends to acquire a 55% stake in Guangxi Laibin Jinshi Mining for 269.5 million yuan [7] - Zhifei Biological's CA111 injection has entered Phase I clinical trials, targeting diabetes and weight loss treatment [8] - Qusleep Technology's specific shareholders plan to reduce their holdings by up to 2.58% of the company's shares [9] Group 4 - Innovation Medical's subsidiary has a product expected to generate revenue of 114,000 yuan in 2025 [11] - Blue Ocean Cursor noted that AI-driven revenue currently constitutes a small portion of overall revenue [12] - *ST Yanshi anticipates a loss for the 2025 fiscal year, with revenue expected to be below 300 million yuan [13] Group 5 - ST Yishite will lift risk warnings and change its stock name, resuming trading on January 14 [14] - Shaoyang Hydraulic clarified that its products do not directly serve commercial aerospace clients [15] - Boss Electric plans to invest 100 million yuan in Youte Smart Kitchen to deepen strategic cooperation [16] Group 6 - Guo An Da's controlling shareholder plans to reduce holdings by up to 3% of the company's shares [17] - *ST Mingjia has lifted the delisting risk warning following the completion of its restructuring plan [18] - Haixiang Pharmaceutical signed an innovative drug cooperation agreement with Wanbangde Pharmaceutical [19] Group 7 - Palm Holdings plans to transfer stakes in two project companies for debt compensation, amounting to 258 million yuan [20] - Bohai Leasing's subsidiary Avolon is projected to have a fleet of 1,132 aircraft by the end of 2025 [21] - Zhenyou Technology reported that satellite internet revenue accounted for approximately 7.15% of total revenue in the first three quarters of 2025 [22] Group 8 - Blue Arrow Electronics intends to acquire at least 51% of Chengdu Xinyi Technology [23] - Shunhao Co. stated that its investment in Tianshu Chuangxin will have a minimal impact on its 2025 performance [24][25] - Baichuan Co.'s deputy general manager plans to reduce holdings by up to 0.65% of the company's shares [26] Group 9 - Zhewen Interconnect reported that its GEO business has not yet formed a mature profit model [27] - XW Communication's controlling shareholder plans to reduce holdings by up to 1% of the company's shares [28] - Electric Science Digital indicated that its satellite communication products are not its main business [29] Group 10 - Bojun Technology expects a net profit increase of 35%-65% for 2025, projecting a profit of 828-1,012 million yuan [30] - Rongchang Bio signed a licensing agreement for the RC148 drug with AbbVie, with an initial payment of 650 million USD [31] - Guoxin Technology's state investment fund plans to reduce holdings by up to 2.37% of the company's shares [32] Group 11 - Hengxuan Technology's controlling shareholder plans to reduce holdings by up to 3% of the company's shares [33][34] - *ST Chengchang announced a stock suspension for investigation due to abnormal trading [35] - Zhongji Xuchuang's subsidiary plans to issue warrants to incentivize its core team [36] Group 12 - Zhuoshengwei expects a net loss of 255-295 million yuan for 2025 [37] - Pingtan Development anticipates a loss for the 2025 fiscal year [38] - Nanjing Bank's major shareholder increased its stake by 123.472 million shares [39] Group 13 - Jingao Technology expects a net loss of 4.5-4.8 billion yuan for 2025 [40] - Mingyang Smart plans to acquire control of Dehua Company, with stock suspension [41] - Vanadium Titanium Co. anticipates a loss for the 2025 fiscal year [42][43] Group 14 - Tianzhihang announced a delay in its "Smart Medical Center Construction Project" [44]

Summary of Key Points Core Viewpoint - Multiple shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership and investor sentiment in the market [1]. Shareholder Reductions - Hengxuan Technology: Shareholders including Ningbo Yibifu plan to reduce their holdings by up to 1.50% [1]. - Guoxin Technology: Industry fund shareholders intend to reduce their stakes by up to 2.37% [1]. - Qusleep Technology: Shareholder Kuanzhai Cultural plans to reduce holdings by no more than 1.98% [1]. - Xinwei Communication: General Manager Peng Hao aims to reduce his stake by up to 1% [1]. - Guoanda: Shareholder Hong Junlong plans to reduce his holdings by up to 1.2761% [1]. - Zhuoyue New Energy: Controlling shareholders intend to reduce their stakes by up to 3.00% [1]. - Haibo Heavy Industry: Actual controller Zhang Haibo plans to reduce his stake by up to 3% [1]. - Sanyou Medical: Shareholders Xu Nong and Liu Mingyan plan to reduce their holdings by up to 2.00% [1]. - Saifen Technology: Multiple shareholders intend to reduce their stakes by up to 6% [1]. - Fangyuan Shares: Shareholder Betterry plans to reduce holdings by no more than 510.17 million shares [1]. - Qiutian Micro: Beihai Chengyu plans to reduce holdings by up to 0.83% [1]. - Diaoda Shares: Controlling shareholders plan to reduce their stakes by up to 3% [1]. - Maidi Technology: Shareholder Weng Kang plans to reduce holdings by 520.29 million shares [1]. Other Notable Events - *ST Yanshi: The company's stock may face delisting [1]. - Jin Yi Technology: The company has terminated the issuance of shares to specific targets and signed relevant termination agreements [1].

格隆汇1月12日丨海波重科(300517.SZ)公布，控股股东、实际控制人张海波先生计划自本公告披露之日 起15个交易日后的3个月内（即2026年2月3日至2026年5月2日，根据法律、法规及规范性文件规定不得 进行减持的期间除外）以大宗交易方式减持本公司股份合计不超过3,990,000股（占公司总股本比例 1.99%，占公司扣除回购专用账户股份后总股本的比例为2.00%），以集中竞价方式减持本公司股份合 计不超过1,990,000股（占公司总股本比例0.99%，占公司扣除回购专用账户股份后总股本的比例为 1.00%）。 ...

人民财讯1月12日电，海波重科(300517)1月12日公告，公司控股股东、实控人张海波计划15个交易日后 的3个月内，以大宗交易方式减持公司股份合计不超过399万股（占公司总股本的1.99%），以集中竞价 方式减持公司股份合计不超过199万股（占公司总股本的0.99%）。 转自：证券时报 ...

海波重科（300517）(300517.SZ)发布公告，公司控股股东、实际控制人张海波先生计划自本公告披露 之日起15个交易日后的3个月内(即2026年2月3日至2026年5月2日，根据法律、法规及规范性文件规定不 得进行减持的期间除外)以大宗交易方式减持本公司股份合计不超过399万股(占公司总股本比例1.99%， 占公司扣除回购专用账户股份后总股本的比例为2.00%)，以集中竞价方式减持本公司股份合计不超过 199万股(占公司总股本比例0.99%，占公司扣除回购专用账户股份后总股本的比例为1.00%)。 ...